Print Page   |   Contact Us   |   Sign In   |   Join
FDA Workshop: Clinical Risk in the Postmarket Environment
Tell a Friend About This EventTell a Friend
 

The purpose of the workshop is to provide a forum for an interactive discussion on assessing changes in medical device risk as quality and safety situations arise in the postmarket setting when a patient, operator, or member of the public actually uses the device.

4/21/2015
When: April 21, 2015
8:80 a.m.
Where: FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31, Room 1503 (the Great Room)
Silver Spring, Maryland  20993
United States
Contact: Jean M. Cooper
301-796-6141

« Go to Upcoming Event List  

 

Public FDA Workshop: Clinical Considerations of Risk in the Postmarket Environment

The Food and Drug Administration (FDA) is announcing a public Workshop entitled “Clinical Considerations of Risk in the Postmarket Environment."

The purpose of the workshop is to provide a forum for an interactive discussion on assessing changes in medical device risk as quality and safety situations arise in the postmarket setting when a patient, operator, or member of the public actually uses the device.

The meeting will also be webcast.

Visit the FDA website for more information, agenda.

 

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal